Human Chorionic Gonadotropin
HCG
Human Chorionic Gonadotropin is a pregnancy supporting hormone extracted from the urine of pregnant women and is widely used as an Ovulation Trigger that helps with the final maturation of the eggs and triggers the ovaries to release the mature eggs (ovulation) in women undergoing Assisted Reproductive Technology (ART) like IUI, IVF and ICSI. It also stimulates the corpus luteum to secrete progesterone to prepare the lining of the uterus for implantation of the fertilized egg.
HCG
Human Chorionic Gonadotropin is a pregnancy supporting hormone extracted from the urine of pregnant women and is widely used as an Ovulation Trigger that helps with the final maturation of the eggs and triggers the ovaries to release the mature eggs (ovulation) in women undergoing Assisted Reproductive Technology (ART) like IUI, IVF and ICSI. It also stimulates the corpus luteum to secrete progesterone to prepare the lining of the uterus for implantation of the fertilized egg.
.
Therapeutic Uses in the Female:
- Ovulation induction in subfertility due to anovulation or impaired follicle-ripening.
- Preparation of follicles for puncture in controlled ovarian hyperstimulation programs (for medically assisted reproductive techniques).
- Luteal phase support.
Therapeutic Uses in the Male:
- Hypogonadotropic hypogonadism (also cases of idiopathic dysspermias have shown a positive response to gonadotropins).
- Delayed puberty associated with insufficient gonadotropic pituitary function.
- Cryptorchidism, not due to anatomical obstruction.
- Preoperative preparation of ectopic testes
Available Formulations/Strengths
- 500 IU / 1000 IU / 1500 IU / 2000 IU / 5000 IU / 7500 IU / 10000 IU
Available in
- Lyophilized or powder form (to be reconstituted)
- Liquid form (Ready to use)
Method of Administration
- Intramuscular or subcutaneous use by registered practitioners.
DISCLAIMER: †PUBERGENTM is a trademark of Sanzyme Private Limited excluding India. This disclosure does not intend to market and commercialize PUBERGENTM in India but for export purposes only.
Visited 476 times, 3 visit(s) today
Since 1969, when we entered into a Joint Venture with Sankyo (now Daiichi-Sankyo) to make gonadotropins to export to Japan, we’ve been at the forefront of biological hormones, and today we have the necessary technological foundation to do path breaking work.